1. Home
  2. RZLT vs DOMO Comparison

RZLT vs DOMO Comparison

Compare RZLT & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • DOMO
  • Stock Information
  • Founded
  • RZLT 2010
  • DOMO 2010
  • Country
  • RZLT United States
  • DOMO United States
  • Employees
  • RZLT N/A
  • DOMO N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • RZLT Health Care
  • DOMO Technology
  • Exchange
  • RZLT Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • RZLT 819.3M
  • DOMO 707.1M
  • IPO Year
  • RZLT N/A
  • DOMO 2018
  • Fundamental
  • Price
  • RZLT $9.98
  • DOMO $13.98
  • Analyst Decision
  • RZLT Strong Buy
  • DOMO Buy
  • Analyst Count
  • RZLT 7
  • DOMO 8
  • Target Price
  • RZLT $14.86
  • DOMO $15.13
  • AVG Volume (30 Days)
  • RZLT 1.4M
  • DOMO 655.7K
  • Earning Date
  • RZLT 11-07-2025
  • DOMO 12-04-2025
  • Dividend Yield
  • RZLT N/A
  • DOMO N/A
  • EPS Growth
  • RZLT N/A
  • DOMO N/A
  • EPS
  • RZLT N/A
  • DOMO N/A
  • Revenue
  • RZLT N/A
  • DOMO $318,363,000.00
  • Revenue This Year
  • RZLT N/A
  • DOMO $2.32
  • Revenue Next Year
  • RZLT N/A
  • DOMO $2.72
  • P/E Ratio
  • RZLT N/A
  • DOMO N/A
  • Revenue Growth
  • RZLT N/A
  • DOMO N/A
  • 52 Week Low
  • RZLT $2.22
  • DOMO $6.01
  • 52 Week High
  • RZLT $10.04
  • DOMO $18.49
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 63.37
  • DOMO 44.47
  • Support Level
  • RZLT $9.00
  • DOMO $13.52
  • Resistance Level
  • RZLT $10.00
  • DOMO $14.34
  • Average True Range (ATR)
  • RZLT 0.56
  • DOMO 0.56
  • MACD
  • RZLT 0.04
  • DOMO 0.15
  • Stochastic Oscillator
  • RZLT 91.82
  • DOMO 68.14

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: